Caveolin as a potential drug target for cardiovascular protection

21Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Caveolae and caveolin are key players in a number of disease processes. Current research indicates that caveolins play a significant role in cardiovascular disease and dysfunction. The far-reaching roles of caveolins in disease and dysfunction make them particularly notable therapeutic targets. In particular, caveolin-1 (Cav-1) and caveolin-3 (Cav-3) have been identified as potential regulators of vascular dysfunction and heart disease and might even confer cardiac protection in certain settings. Such a central role in vascular health therefore makes manipulation of Cav-1/3 function or expression levels clear therapeutic targets in a variety of cardiovascular related disease states. Here, we highlight the role of Cav-1 and Cav-3 in cardiovascular health and explore the potential of Cav-1 and Cav-3 derived experimental therapeutics. © 2012 Sellers, Trane and Bernatchez.

Cite

CITATION STYLE

APA

Sellers, S. L., Trane, A. E., & Bernatchez, P. N. (2012). Caveolin as a potential drug target for cardiovascular protection. Frontiers in Physiology. https://doi.org/10.3389/fphys.2012.00280

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free